vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and PARK NATIONAL CORP (PRK). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $168.3M, roughly 1.2× PARK NATIONAL CORP). PARK NATIONAL CORP runs the higher net margin — 25.3% vs -14.6%, a 39.9% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 2.2%). PARK NATIONAL CORP produced more free cash flow last quarter ($191.9M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 4.9%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
National Retail Systems, Inc. (NRS) includes Keystone Freight Corp. & National Retail Transportation, Inc. (NRT). NRS is an asset based 3PL founded in 1952. It is headquartered in Lyndhurst, New Jersey, United States.
AXSM vs PRK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $168.3M |
| Net Profit | $-28.6M | $42.6M |
| Gross Margin | — | — |
| Operating Margin | -13.8% | — |
| Net Margin | -14.6% | 25.3% |
| Revenue YoY | 65.0% | 2.2% |
| Net Profit YoY | 61.9% | 10.4% |
| EPS (diluted) | $-0.55 | $2.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $168.3M | ||
| Q3 25 | $171.0M | $169.5M | ||
| Q2 25 | $150.0M | $168.7M | ||
| Q1 25 | $121.5M | $157.9M | ||
| Q4 24 | $118.8M | $164.7M | ||
| Q3 24 | $104.8M | $170.3M | ||
| Q2 24 | $87.2M | $157.7M | ||
| Q1 24 | $75.0M | $152.8M |
| Q4 25 | $-28.6M | $42.6M | ||
| Q3 25 | $-47.2M | $47.2M | ||
| Q2 25 | $-48.0M | $48.1M | ||
| Q1 25 | $-59.4M | $42.2M | ||
| Q4 24 | $-74.9M | $38.6M | ||
| Q3 24 | $-64.6M | $38.2M | ||
| Q2 24 | $-79.3M | $39.4M | ||
| Q1 24 | $-68.4M | $35.2M |
| Q4 25 | -13.8% | — | ||
| Q3 25 | -27.0% | 34.3% | ||
| Q2 25 | -24.5% | 35.2% | ||
| Q1 25 | -46.9% | 32.4% | ||
| Q4 24 | -61.1% | — | ||
| Q3 24 | -59.8% | 27.4% | ||
| Q2 24 | -89.5% | 30.6% | ||
| Q1 24 | -89.7% | 27.8% |
| Q4 25 | -14.6% | 25.3% | ||
| Q3 25 | -27.6% | 27.8% | ||
| Q2 25 | -32.0% | 28.5% | ||
| Q1 25 | -48.9% | 26.7% | ||
| Q4 24 | -63.1% | 23.5% | ||
| Q3 24 | -61.7% | 22.4% | ||
| Q2 24 | -91.0% | 25.0% | ||
| Q1 24 | -91.1% | 23.0% |
| Q4 25 | $-0.55 | $2.62 | ||
| Q3 25 | $-0.94 | $2.92 | ||
| Q2 25 | $-0.97 | $2.97 | ||
| Q1 25 | $-1.22 | $2.60 | ||
| Q4 24 | $-1.54 | $2.38 | ||
| Q3 24 | $-1.34 | $2.35 | ||
| Q2 24 | $-1.67 | $2.42 | ||
| Q1 24 | $-1.44 | $2.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $233.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | $1.4B |
| Total Assets | $689.8M | $9.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $233.5M | ||
| Q3 25 | $325.3M | $218.9M | ||
| Q2 25 | $303.0M | $193.1M | ||
| Q1 25 | $300.9M | $237.6M | ||
| Q4 24 | $315.4M | $160.6M | ||
| Q3 24 | $327.3M | $201.7M | ||
| Q2 24 | $315.7M | $261.5M | ||
| Q1 24 | $331.4M | $306.1M |
| Q4 25 | $88.3M | $1.4B | ||
| Q3 25 | $73.7M | $1.3B | ||
| Q2 25 | $73.1M | $1.3B | ||
| Q1 25 | $53.2M | $1.3B | ||
| Q4 24 | $57.0M | $1.2B | ||
| Q3 24 | $92.9M | $1.2B | ||
| Q2 24 | $102.9M | $1.2B | ||
| Q1 24 | $144.0M | $1.2B |
| Q4 25 | $689.8M | $9.8B | ||
| Q3 25 | $669.3M | $9.9B | ||
| Q2 25 | $639.8M | $9.9B | ||
| Q1 25 | $596.7M | $9.9B | ||
| Q4 24 | $568.5M | $9.8B | ||
| Q3 24 | $561.5M | $9.9B | ||
| Q2 24 | $548.2M | $9.9B | ||
| Q1 24 | $545.7M | $9.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $198.3M |
| Free Cash FlowOCF − Capex | $-18.7M | $191.9M |
| FCF MarginFCF / Revenue | -9.6% | 114.1% |
| Capex IntensityCapex / Revenue | 0.0% | 3.8% |
| Cash ConversionOCF / Net Profit | — | 4.65× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $328.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $198.3M | ||
| Q3 25 | $1.0M | $52.6M | ||
| Q2 25 | $-32.4M | $49.7M | ||
| Q1 25 | $-43.4M | $37.9M | ||
| Q4 24 | $-26.2M | $178.8M | ||
| Q3 24 | $-18.6M | $43.8M | ||
| Q2 24 | $-30.1M | $50.9M | ||
| Q1 24 | $-53.5M | $35.0M |
| Q4 25 | $-18.7M | $191.9M | ||
| Q3 25 | $988.0K | $51.1M | ||
| Q2 25 | $-32.4M | $48.4M | ||
| Q1 25 | $-43.7M | $36.8M | ||
| Q4 24 | $-26.2M | $169.7M | ||
| Q3 24 | $-18.7M | $41.7M | ||
| Q2 24 | $-30.2M | $49.0M | ||
| Q1 24 | $-53.6M | $31.9M |
| Q4 25 | -9.6% | 114.1% | ||
| Q3 25 | 0.6% | 30.1% | ||
| Q2 25 | -21.6% | 28.7% | ||
| Q1 25 | -36.0% | 23.3% | ||
| Q4 24 | -22.1% | 103.0% | ||
| Q3 24 | -17.9% | 24.5% | ||
| Q2 24 | -34.6% | 31.1% | ||
| Q1 24 | -71.4% | 20.8% |
| Q4 25 | 0.0% | 3.8% | ||
| Q3 25 | 0.0% | 0.9% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 0.3% | 0.7% | ||
| Q4 24 | 0.0% | 5.6% | ||
| Q3 24 | 0.1% | 1.2% | ||
| Q2 24 | 0.1% | 1.2% | ||
| Q1 24 | 0.1% | 2.1% |
| Q4 25 | — | 4.65× | ||
| Q3 25 | — | 1.11× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | — | 4.63× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 1.29× | ||
| Q1 24 | — | 0.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
